T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Abbott
ABT
$194B
| $990M | 0.16% |
10,226,688
+813,894
| +9% | +$86.7M |
|
127
CSX Corp
CSX
$93.6B
| $978M | 0.16% |
36,723,434
-7,359,455
| -17% | -$229M |
|
128
Booz Allen Hamilton
BAH
$9.47B
| $977M | 0.16% |
10,580,594
-2,427,396
| -19% | -$230M |
|
129
Amphenol
APH
$208B
| $976M | 0.16% |
29,162,472
-13,554,952
| -32% | -$492M |
|
130
HCA Healthcare
HCA
$89B
| $975M | 0.16% |
5,305,424
+354,202
| +7% | +$70.6M |
|
|
FITB
131
Fifth Third Bancorp
FITB
$52.7B
| $972M | 0.16% |
30,415,133
+1,507,964
| +5% | +$52M |
|
132
Medtronic
MDT
$116B
| $967M | 0.16% |
11,972,621
+538,836
| +5% | +$48.4M |
|
133
SBA Communications
SBAC
$19.6B
| $967M | 0.16% |
3,396,193
+407,347
| +14% | +$132M |
|
134
Huntington Bancshares
HBAN
$36.3B
| $953M | 0.16% |
72,288,893
+3,025,509
| +4% | +$40.4M |
|
135
West Pharmaceutical
WST
$24.6B
| $952M | 0.16% |
3,870,122
-2,377,451
| -38% | -$724M |
|
136
Alibaba
BABA
$295B
| $927M | 0.15% |
11,568,760
+1,588,857
| +16% | +$151M |
|
137
Burlington
BURL
$22.1B
| $926M | 0.15% |
8,271,831
-1,440,759
| -15% | -$210M |
|
138
Eaton
ETN
$177B
| $922M | 0.15% |
6,916,352
+1,533,229
| +28% | +$215M |
|
139
TotalEnergies
TTE
$192B
| $920M | 0.15% |
19,651,140
-5,021,482
| -20% | -$252M |
|
140
CVS Health
CVS
$122B
| $916M | 0.15% |
9,609,163
-202,085
| -2% | -$20M |
|
141
Kimberly-Clark
KMB
$36.5B
| $899M | 0.15% |
7,984,860
-640,511
| -7% | -$83.3M |
|
142
Conagra Brands
CAG
$7.3B
| $893M | 0.15% |
27,370,821
-548,086
| -2% | -$18.8M |
|
143
Cadence Design Systems
CDNS
$88.7B
| $886M | 0.15% |
5,419,304
+2,685,677
| +98% | +$462M |
|
144
Equitable Holdings
EQH
$14.2B
| $872M | 0.14% |
33,106,476
-1,543,824
| -4% | -$43.9M |
|
145
Shopify
SHOP
$195B
| $865M | 0.14% |
32,098,494
+1,094,722
| +4% | +$37.2M |
|
146
International Paper
IP
$21.7B
| $860M | 0.14% |
27,117,922
-713,499
| -3% | -$29.2M |
|
147
Equinix
EQIX
$106B
| $860M | 0.14% |
1,511,192
-217,356
| -13% | -$142M |
|
148
Trade Desk
TTD
$6.44B
| $855M | 0.14% |
14,311,306
-11,828,053
| -45% | -$673M |
|
149
State Street
STT
$52.2B
| $847M | 0.14% |
13,929,437
-1,920,670
| -12% | -$131M |
|
150
Avantor
AVTR
$9.31B
| $831M | 0.14% |
42,406,283
-43,750,270
| -51% | -$1.17B |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.